BR8907457A - Inibidores de interleucina-1 - Google Patents

Inibidores de interleucina-1

Info

Publication number
BR8907457A
BR8907457A BR898907457A BR8907457A BR8907457A BR 8907457 A BR8907457 A BR 8907457A BR 898907457 A BR898907457 A BR 898907457A BR 8907457 A BR8907457 A BR 8907457A BR 8907457 A BR8907457 A BR 8907457A
Authority
BR
Brazil
Prior art keywords
interleucin
inhibitors
Prior art date
Application number
BR898907457A
Other languages
English (en)
Inventor
Charles H Hannon
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of BR8907457A publication Critical patent/BR8907457A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR898907457A 1988-05-27 1989-05-25 Inibidores de interleucina-1 BR8907457A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (1)

Publication Number Publication Date
BR8907457A true BR8907457A (pt) 1991-04-02

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
BR898907457A BR8907457A (pt) 1988-05-27 1989-05-25 Inibidores de interleucina-1

Country Status (9)

Country Link
JP (2) JP3192651B2 (pt)
KR (1) KR970002917B1 (pt)
BR (1) BR8907457A (pt)
DK (1) DK172763B1 (pt)
FI (2) FI109206B (pt)
HU (3) HU9803037D0 (pt)
NO (2) NO316122B1 (pt)
OA (1) OA09631A (pt)
WO (1) WO1989011540A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
EP0534978B1 (en) * 1990-05-01 1999-03-24 Chiron Corporation Interleukin-1 antagonist and uses thereof
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US5747444A (en) * 1990-10-09 1998-05-05 Chiron Corporation Method of treating graft-versus-host disease
ZA921120B (en) 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
WO2003035048A2 (en) * 2001-10-26 2003-05-01 Novartis Ag Methods for the treatment of osteoarthritis and compositions thereof
EP2314316A1 (en) 2002-04-05 2011-04-27 Amgen, Inc Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
CA2574881C (en) 2004-08-04 2013-01-08 Amgen Inc. Antibodies to dkk-1
RS56743B1 (sr) 2007-08-21 2018-03-30 Amgen Inc Humani c-fms antigen vezujući proteini
CA2737056C (en) * 2008-09-12 2018-10-30 Xbiotech Inc. Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
WO2012122985A1 (en) 2011-03-14 2012-09-20 University Of Copenhagen Antagonists of the interleukin- 1 receptor
CN103492416A (zh) 2011-04-15 2014-01-01 默克专利股份公司 用于癌症中使用的抗il-1r1抑制剂
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
AU2017229575A1 (en) 2016-03-08 2018-09-27 Janssen Biotech, Inc. GITR antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法

Also Published As

Publication number Publication date
HU215434B (hu) 1999-04-28
NO905090D0 (no) 1990-11-23
DK172763B1 (da) 1999-07-05
AU633831B2 (en) 1993-02-11
FI20020545L (fi) 2002-03-21
KR970002917B1 (ko) 1997-03-12
JP3192651B2 (ja) 2001-07-30
HU893412D0 (en) 1991-05-28
NO20014783D0 (no) 2001-10-01
HU9803037D0 (en) 1999-11-29
NO905090L (no) 1991-01-28
NO316122B1 (no) 2003-12-15
NO316917B1 (no) 2004-06-21
DK8591A (da) 1991-01-18
JPH03505279A (ja) 1991-11-21
AU3746989A (en) 1989-12-12
FI905812A0 (fi) 1990-11-26
JP2001029093A (ja) 2001-02-06
OA09631A (en) 1993-04-30
DK8591D0 (da) 1991-01-18
NO20014783L (no) 1991-01-28
FI109206B (fi) 2002-06-14
HU222810B1 (hu) 2003-11-28
FI20020545A7 (fi) 2002-03-21
WO1989011540A1 (en) 1989-11-30

Similar Documents

Publication Publication Date Title
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
ATA172889A (de) Furanderivate
ATA900689A (de) Calcitoninpeptide
DK188690A (da) Neutrocyt-aktiverende peptid-2
FI101796B1 (fi) Uusia -glukosidaasi-inhibiittoreita
BR8902098A (pt) Eletrolisador
DK25491A (da) Laasepaavirkningsaggregat
DK113291A (da) Homogent enzymimmunassay
FI890827A7 (fi) Lysyloxidas-inhibitorer.
BR8906898A (pt) Jamela
DK440989D0 (da) Dopamin-beta-hydroxylase inhibitorer
DK69489A (da) Aspartattranscarbamylase-inhibitorer
FI88370B (fi) Roerkapningsanordning
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
KR900004589U (ko) 장기
DK536788A (da) Foldeaeske
ES2024700B3 (es) 3 - ciano - 4 - fenil - pirroles
DD277186A3 (de) Waelzlagerseparator
SE8800391D0 (sv) Stodben for stegar
BR6801430U (pt) Auto-sombreiro
BR8804416A (pt) Papa-mosca
SE8802308D0 (sv) Forseglingsanordning
DK245588D0 (da) Suturclips
BR8803070A (pt) Rende-lapis

Legal Events

Date Code Title Description
FA Application withdrawn
B15K Others concerning applications: alteration of classification

Ipc: C07K 16/18 (2006.01), C07K 14/54 (2006.0